Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
Within just six months of coming out of stealth mode, Scribe Therapeutics, co-founded by Jennifer Doudna, the 2020 Nobel Prize Winner, bagged another $100 million through Series B financing on …
Read More